Reduction in arthritis was accompanied by reduced levels of IL‐6 (Figure 3A) and the inflammatory marker alpha‐1‐acid glycoprotein in sera of animals treated with the TLR9 antagonist (Figure 3B). The gene discussed is TLR9; the disease is arthritic joint disease.